161 related articles for article (PubMed ID: 26725358)
21. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
22. Extranodal nasal-type NK/T-cell lymphoma: computed tomography findings of head and neck involvement.
Kim J; Kim EY; Lee SK; Kim DI; Kim CH; Kim SH; Choi EC
Acta Radiol; 2010 Mar; 51(2):164-9. PubMed ID: 20092373
[TBL] [Abstract][Full Text] [Related]
23. Current and future management of NK/T-cell lymphoma based on clinical trials.
Yamaguchi M
Int J Hematol; 2012 Nov; 96(5):562-71. PubMed ID: 23073619
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
[TBL] [Abstract][Full Text] [Related]
25. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.
Kim SJ; Yoon SE; Kim WS
J Hematol Oncol; 2018 Dec; 11(1):140. PubMed ID: 30567593
[TBL] [Abstract][Full Text] [Related]
26. Nasal-type extranodal NK/T-cell lymphoma presenting as recurrent periorbital cellulitis.
Hussein MA; Boyle S; Abdulrahman S; Fennessy B
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795266
[TBL] [Abstract][Full Text] [Related]
27. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
29. Natural killer/T-cell lymphoma, nasal type, masquerading as recalcitrant periodontitis in a patient with a diagnosis of Wegener's granulomatosis.
Sokołowska-Wojdyło M; Florek A; Barańska-Rybak W; Sikorska M; Starzyńska A; Drogoszewska B; Włodarkiewicz A
Am J Med Sci; 2013 Feb; 345(2):163-7. PubMed ID: 23111392
[TBL] [Abstract][Full Text] [Related]
30. Extranodal sinonasal natural killer/T-cell lymphoma presenting as chronic sinusitis and necrotic wound infection.
Karaman E; Yilmaz M; Alimoglu Y; Edizer DT; Isildak H; Ozek H
J Craniofac Surg; 2009 Nov; 20(6):2095-6. PubMed ID: 19881363
[TBL] [Abstract][Full Text] [Related]
31. [A case of nasal NK/T cell lymphoma in Africa].
Kouassi YM; Vroh BT; Amelin IH; Buraïma F; N'Gattia KV; Kouassi JE; Tanon-anoh MJ; Kouassi B; Portmann D
Rev Laryngol Otol Rhinol (Bord); 2011; 132(4-5):255-7. PubMed ID: 22908552
[TBL] [Abstract][Full Text] [Related]
32. Primary CNS natural killer/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature.
Prajapati HJ; Vincentelli C; Hwang SN; Voloschin A; Crocker I; Dehkharghani S
J Clin Oncol; 2014 Mar; 32(8):e26-9. PubMed ID: 24419127
[No Abstract] [Full Text] [Related]
33. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
34. Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow.
Rezk SA; Huang Q
Int J Clin Exp Pathol; 2011; 4(7):713-7. PubMed ID: 22076172
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
36. Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Yamaguchi M; Suzuki R; Kim SJ; Ko YH; Oguchi M; Asano N; Miyazaki K; Terui Y; Kubota N; Maeda T; Kobayashi Y; Amaki J; Soejima T; Saito B; Shimoda E; Fukuhara N; Tsukamoto N; Shimada K; Choi I; Utsumi T; Ejima Y; Kim WS; Katayama N
Cancer Sci; 2018 Jun; 109(6):2056-2062. PubMed ID: 29601137
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Hotta T; Tsukasaki K; Oshimi K
J Clin Oncol; 2012 Nov; 30(32):4044-6. PubMed ID: 23045573
[No Abstract] [Full Text] [Related]
38. CD56-negative extranodal nasal type NK/T-cell lymphoma.
Miles RR; Afify Z; Yaish H; Perkins SL
Pediatr Blood Cancer; 2010 Jul; 55(1):186-9. PubMed ID: 20486184
[TBL] [Abstract][Full Text] [Related]
39. Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.
Hattori Y; Murai T; Iwata H; Uchiyama K; Mimura M; Kato E; Murata R; Shibamoto Y
Jpn J Radiol; 2016 Apr; 34(4):292-9. PubMed ID: 26852128
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
